2024-03-13 19:32:06 ET
scPharmaceuticals Inc (SCPH)
Q4 2023 Results Conference Call
March 13, 2024 04:30 PM ET
Company Participants
PJ Kelleher - LifeSci Advisors
John Tucker - Chief Executive Officer
Steve Parsons - Senior Vice President, Commercial
Rachael Nokes - Chief Financial Officer
John Mohr - Senior Vice President of Clinical Development & Medical Affairs
Conference Call Participants
Rosa Chen - Leerink Partners
Stacy Ku - TD Cowen
Douglas Tsao - H. C. Wainwright
Chase Knickerbocker - Craig-Hallum
Naz Rahman - Maxim Group
Presentation
Operator
Greetings, and welcome to scPharmaceuticals Fourth Quarter and Full year 2023 Earnings Conference Call. At this time, all participants are in listen-only mode. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce PJ Kelleher, with LifeSci Advisors. Thank you. You may begin.
PJ Kelleher
Thank you, operator.
Before turning the call over to management, I would like to make the following remarks concerning forward-looking statements. All statements on this conference call, other than historical facts, are forward-looking statements within the meeting of the Federal Securities Laws, including, but not limited to statements regarding ScPharmaceuticals expected future financial results and management's expectations and plans for the business in FUROSCIX. The words anticipate, believe, estimate, expect, intend, guidance, confidence, target, project, and other similar expressions are typically used to identify such forward-looking statements.
These forward-looking statements are not guarantees of future performance and may involve and are subject to certain risks and uncertainties and other important factors that may affect ScPharmaceuticals’ business, financial condition, and other operating results. These include, but are not limited to, the risk factors and other qualifications contained in ScPharmaceuticals Annual Report on Form 10-K, quarterly reports on Form 10-Q, and other reports filed by the company with the SEC to which your attention is directed.
Actual outcomes and results may differ materially from what is expressed or implied by these forward-looking statements. Any forward-looking statements made in this conference call, including responses to your questions, are based on current expectations as of today, and ScPharmaceuticals especially disclaim any intent or obligation to update these forward-looking statements, except as required by law.
It is now my pleasure to turn the call over to Mr. John Tucker, Chief Executive Officer of ScPharmaceuticals. John?...
Read the full article on Seeking Alpha
For further details see:
scPharmaceuticals Inc (SCPH) Q4 2023 Earnings Call Transcript